The cancer comes back. (Remember that dandelion?) We learn that recurrence is a common feature of ovarian cancer because early detection is so difficult and there is no way to screen for it. But asking the question ‘why can’t we see it coming?’ leads me on a journey to learn more about - not the ovaries - but the fallopian tubes, and new innovations to try and get ahead of this cancer. This episode features: Dr James Bentley from Nova Scotia Health. Alison Ross, Director of Knowledge Mobilization at Ovarian Cancer Canada. Jennifer Barton, Director of the Bio5 Institute at the University of Arizona. For more background on this episode, go to https://overlookedpod.com/, where you can also get in touch with us.
Featuring:
Dr James Bentley from Nova Scotia Health.
Alison Ross, Director of Knowledge Mobilization at Ovarian Cancer Canada.
Jennifer Barton, Director of the Bio5 Institute at the University of Arizona.
For more background on this episode, head to overlookedpod.com, where you can also get in touch with us.
How you can support the show: